Veitch David 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Mar 7, 2013
Insider Transaction Report
Form 4
Veitch David
Pres, Savient Pharma Ireland
Transactions
- Award
Option to Purchase Common Stock
2013-03-05+110,000→ 110,000 totalExercise: $0.94Exp: 2023-03-05→ Common Stock (110,000 underlying) - Award
Option to Purchase Common Stock
2013-03-05+162,500→ 162,500 totalExercise: $0.94Exp: 2022-01-16→ Common Stock (162,500 underlying)
Footnotes (2)
- [F1]These options will vest in proportional 25% increments on each of the first four anniversaries of the grant date, March 5, 2013.
- [F2]These options were granted pursuant to the terms of Mr. Veitch's employment and vest as follows: 25% on the first anniversary of his commencement date, January 16, 2012, and an additional 6.25% at the end of each successive three-month period following the first anniversary,